Literature DB >> 785503

Limberg flap coverage for axillary defects resulting from excision of hidradenitis suppurativa.

J O'Brien, J Wysocki, G Anastasi.   

Abstract

After excision of the apocrine gland containing tissue, we advocate wound closure with a Limberg flap. Our results to date suggest that this approach, which combines definitive treatment with surgical economy, warrants an aggressive attitude toward even early cases of axillary "apocrinitis".

Entities:  

Mesh:

Year:  1976        PMID: 785503     DOI: 10.1097/00006534-197609000-00017

Source DB:  PubMed          Journal:  Plast Reconstr Surg        ISSN: 0032-1052            Impact factor:   4.730


  7 in total

1.  Recurrence after surgical treatment of hidradenitis suppurativa.

Authors:  B J Harrison; M Mudge; L E Hughes
Journal:  Br Med J (Clin Res Ed)       Date:  1987-02-21

2.  Hidradenitis suppurativa: review of the literature and management of the axillary lesion.

Authors:  E B Mustafa; S D Ali; L H Kurtz
Journal:  J Natl Med Assoc       Date:  1980-03       Impact factor: 1.798

Review 3.  [Surgical treatment options for hidradenitis suppurativa/acne inversa].

Authors:  L Scholl; S Hessam; S Reitenbach; F G Bechara
Journal:  Hautarzt       Date:  2018-02       Impact factor: 0.751

4.  A comparison of skin grafting and healing by granulation, following axillary excision for hidradenitis suppurativa.

Authors:  W P Morgan; K G Harding; L E Hughes
Journal:  Ann R Coll Surg Engl       Date:  1983-07       Impact factor: 1.891

5.  Radical surgical excision and use of lateral thoracic flap for intractable axillary hidradenitis suppurativa.

Authors:  Wan-Lin Teo; Yee-Siang Ong; Bien-Keem Tan
Journal:  Arch Plast Surg       Date:  2012-11-14

6.  Simultaneous Bilateral Reconstruction of the Axilla with Posterior Arm Flap in Recurrent Hidradenitis Suppurativa.

Authors:  Kingsly Paul M; Geley Ete; Felix Cordelia M J; Anirudha K Akamanchi; Shwetha Agarwal
Journal:  Indian J Plast Surg       Date:  2022-02-16

7.  Hydradenitis suppurativa.

Authors:  B A Bell; H Ellis
Journal:  J R Soc Med       Date:  1978-07       Impact factor: 18.000

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.